Literature DB >> 22123592

Pelvic inflammatory disease and ovarian cancer.

Kelby M Cheong.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22123592     DOI： 10.1016/S1470-2045(11)70351-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway.

Authors:  Ming-Hui Zhang; Hui-Hui Zhang; Xue-Hua Du; Jie Gao; Chao Li; Hui-Rong Shi; Shang-Ze Li
Journal:  Oncogene       Date:  2019-09-02       Impact factor: 9.867

2.  Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study.

Authors:  Cheng-Che Shen; Li-Yu Hu; Albert C Yang; Yung-Yen Chiang; Jeng-Hsiu Hung; Shih-Jen Tsai
Journal:  BMC Cancer       Date:  2016-11-03       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.